Integra Lifesciences Holdings (IART) Inventory (2009 - 2026)

Integra Lifesciences Holdings' Inventory history runs 18 years deep, the most recent figure standing at $495.0 million for Q1 2026.

• In Q1 2026, Inventory rose 11.14% year-over-year to $495.0 million; the TTM figure through Mar 2026 stood at $495.0 million (up 11.14% YoY), while the FY2025 annual figure was $492.7 million, up 14.83% from the prior year.
• Inventory came in at $495.0 million for Q1 2026 at Integra Lifesciences Holdings, roughly flat from $492.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $495.0 million in Q1 2026 to a low of $311.1 million in Q3 2022.
• A 5-year average of $401.4 million and a median of $403.4 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory fell 4.92% in 2022 and increased 20.03% in 2023, its largest moves.
• Integra Lifesciences Holdings' Inventory stood at $324.6 million in 2022, then climbed by 20.03% to $389.6 million in 2023, then grew by 10.13% to $429.1 million in 2024, then increased by 14.83% to $492.7 million in 2025, then increased by 0.47% to $495.0 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $495.0 million, $492.7 million, and $489.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison